Decision analysis and screening for Down's syndrome

BMJ 1995; 311 doi: 10.1136/bmj.311.7016.1371c (Published 18 November 1995)
Cite this as: BMJ 1995;311:1371.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. David Murray,
  2. Barry Tennison
  1. Public health officer Director of public health Hertfordshire Health Agency, Welwyn Garden City, Hertfordshire AL8 6JL

    Estimate of uptake of amniocentesis is overoptimistic

    EDITOR,--J Fletcher and colleagues raise many important issues regarding the difficulties in making population policies for antenatal screening for Down's syndrome.1 Unlike in some previous studies, the authors give full attention to a wide range of outcome measures in their comparison of possible alternative policies rather than focusing simply on the number of cases of Down's syndrome detected. They also …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL